Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling
about
Hallmarks of glycosylation in cancerPG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesTumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.Discovery of a Small-Molecule Modulator of Glycosaminoglycan Sulfation.Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer.Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis.Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
P2860
Q26752363-08C054D7-E6E2-4836-982F-2169A555A445Q35470322-9EEE6B85-353F-4BAF-947C-6568495175CCQ35670736-4575F99A-70C3-4BB3-A325-C5F42670CB0BQ36179026-7C8689C5-FB39-4C86-9893-06553AD38BCAQ38238094-5F9965CE-B3ED-49F3-BE64-877219444363Q38290246-3C8BC826-F22D-4E05-B8C4-75F0AB3C1230Q38418286-A5D0699C-48E2-494E-9737-92CCA3A3110AQ38973422-7FC702B2-F63F-462E-A12F-3F361F50F0D1Q39250554-339CEA0F-A9B8-4B83-94D0-7C555222C47FQ39411671-E2EE020E-84D7-47CD-9186-40E01066CC97Q42317502-DB541467-E8E6-492F-B4E8-B4E658DB2657Q46646980-2E339121-9911-47D8-96DC-C3345C43174CQ47104012-26E19A7A-8168-4663-B36E-08556FB3D0F7Q48137993-5385CE8F-A561-49BF-8329-9EC0D13F4ABDQ58705289-A4E80A23-34B4-4EA7-9186-5B85C3F8E0BF
P2860
Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@ast
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@en
type
label
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@ast
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@en
prefLabel
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@ast
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@en
P2093
P2860
P356
P1476
Ovarian cancer cell heparan su ...... factor/EGF receptor signaling
@en
P2093
Claire L Cole
Egle Avizienyte
Graham Rushton
P2860
P304
10488-10501
P356
10.1074/JBC.M113.534263
P407
P577
2014-02-22T00:00:00Z